265 Pill - purple capsule/oblong, 18mm
Pill with imprint 265 is Purple, Capsule/Oblong and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Ascend Laboratories LLC.
Mycophenolate mofetil is used in the treatment of Nephrotic Syndrome; Organ Transplant, Rejection Prophylaxis; Graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 265
Mycophenolate Mofetil
- Imprint
- 265
- Strength
- 500 mg
- Color
- Purple
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ascend Laboratories LLC
- National Drug Code (NDC)
- 67877-0225
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone,
microcrystalline cellulose,
hypromelloses,
polyethylene glycol,
isopropyl alcohol,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "265"
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (61)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
